Issue 3/2009
Content (23 Articles)
Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer
Ingrid Ljuslinder, Irina Golovleva, Roger Henriksson, Kjell Grankvist, Beatrice Malmer, Håkan Hedman
Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
Bryan P Schneider, George W Sledge Jr
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model
Jessica Kalra, Corinna Warburton, Karen Fang, Lincoln Edwards, Tim Daynard, Dawn Waterhouse, Wieslawa Dragowska, Brent W Sutherland, Shoukat Dedhar, Karen Gelmon, Marcel Bally
Links between transforming growth factor-β and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity
Angela Incassati, Alicia Pinderhughes, Rachel Eelkema, Pamela Cowin
Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?
Joan S Lewis-Wambi, V Craig Jordan
Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression
Cecilia Williams, Luisa Helguero, Karin Edvardsson, Lars-Arne Haldosén, Jan-Åke Gustafsson
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer
Aoife J Lowery, Nicola Miller, Amanda Devaney, Roisin E McNeill, Pamela A Davoren, Christophe Lemetre, Vladimir Benes, Sabine Schmidt, Jonathon Blake, Graham Ball, Michael J Kerin
Immunohistochemical characterization of subtypes of male breast carcinoma
Yimin Ge, Nour Sneige, Mahmoud A Eltorky, Zhiqin Wang, E Lin, Yun Gong, Ming Guo
PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture
Gray W Pearson, Tony Hunter
A constant risk for familial breast cancer? A population-based family study
Kamila Czene, Marie Reilly, Per Hall, Mikael Hartman
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
Marilyn L Kwan, Lawrence H Kushi, Erin Weltzien, Benjamin Maring, Susan E Kutner, Regan S Fulton, Marion M Lee, Christine B Ambrosone, Bette J Caan
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
Yutaka Matsuda, Thomas Schlange, Edward J Oakeley, Anne Boulay, Nancy E Hynes
The spatial distribution of radiodense breast tissue: a longitudinal study
Snehal M Pinto Pereira, Valerie A McCormack, Sue M Moss, Isabel dos Santos Silva
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
Frank Wiesmann, Jürgen Veeck, Oliver Galm, Arndt Hartmann, Manel Esteller, Ruth Knüchel, Edgar Dahl
Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy
Christos Markopoulos, Urania Dafni, John Misitzis, Vasilios Zobolas, Evagelos Tzoracoleftherakis, Dimitrios Koukouras, Grigorios Xepapadakis, John Papadiamantis, Basileios Venizelos, Zoh Antonopoulou, Helen Gogas
Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer
Ruben Rene Gonzalez, Amber Watters, Yanbo Xu, Udai P Singh, David R Mann, Bo R Rueda, Manuel L Penichet
HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005
Katri Köninki, Minna Tanner, Anssi Auvinen, Jorma Isola
Challenges in studying the etiology of breast cancer subtypes
Melissa A Troester, Theresa Swift-Scanlan
Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women
Valerie A McCormack, Mitch Dowsett, Elizabeth Folkerd, Nichola Johnson, Claire Palles, Ben Coupland, Jeff M Holly, Sarah J Vinnicombe, Nicholas M Perry, Isabel dos Santos Silva
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
Catherine Alix-Panabières, Jean-Pierre Vendrell, Monique Slijper, Olivier Pellé, Eric Barbotte, Grégoire Mercier, William Jacot, Michel Fabbro, Klaus Pantel
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
André Albergaria, Joana Paredes, Bárbara Sousa, Fernanda Milanezi, Vítor Carneiro, Joana Bastos, Sandra Costa, Daniella Vieira, Nair Lopes, Eric W Lam, Nuno Lunet, Fernando Schmitt
Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer
Fiona M Foster, Thomas W Owens, Jolanta Tanianis-Hughes, Robert B Clarke, Keith Brennan, Nigel J Bundred, Charles H Streuli
The role of YY1 in reduced HP1α gene expression in invasive human breast cancer cells
Jason G Lieberthal, Marissa Kaminsky, Christopher N Parkhurst, Naoko Tanese